A Membrane‐Centric Plasma Lipidomic Signature of Response to Long‐Acting Naltrexone in Alcohol Use Disorder
Addiction Biology · 2026-05 · 31 (5)
DOI: 10.1111/adb.70165 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Addiction Biology, online erschienen am 12.05.2026. Verfasst von Liyao Huang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Naltrexone, Alcoholism, Narcotic Antagonists. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Health High-Level Talent Scientific Research Project, Key Project of Natural Science Foundation of Hunan Province, Hunan Provincial Clinical Research Center for Addiction Disorder.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Long‐acting naltrexone is a first‐line pharmacotherapy for alcohol use disorder (AUD), but clinical response is heterogeneous and the underlying biology remains incompletely understood. In a randomised, double‐blind, placebo‐controlled trial of naltrexone implants ( n = 70), the prespecified primary endpoint—percentage of heavy‐drinking days (PHDD) over 24 weeks—favoured naltrexone (median 1.49% vs. 13.39%; p = 0.042). In a prespecified Week‐12 mechanistic lipidomics substudy, untargeted liquid chromatography–mass spectrometry (LC–MS) profiling was performed in a responder‐enriched subset comprising naltrexone responders (RN, n = 18), placebo‐treated participants (PL, n = 10) and age‐ and BMI‐matched healthy male controls (HC, n = 10). We derived membrane‐related indices reflecting two prespecified axes of phospholipid remodelling: headgroup balance (PC/PE) and acyl‐chain composition (arachidonic acid [AA] and n‐3 polyunsaturated fatty acids within phospholipid pools). RN showed higher PC/PE and coordinated acyl‐chain shifts versus PL, with species‐level changes preferentially moving toward the healthy‐control direction. Exploratory analyses in naltrexone nonresponders (NR, n = 10) revealed partial Lands‐cycle‐related shifts but lacked the broader dual‐axis configuration observed in RN. In RN + PL ( n = 28), higher n‐3 in PE and lower AA in PE at Week 12 were prospectively associated with greater subsequent heavy‐drinking burden. These findings support a dual‐axis membrane remodelling phenotype associated with naltrexone response and prospectively linked to heavy‐drinking burden in AUD, providing a biologically grounded framework for future mechanistic and biomarker studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The School of Clinical Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
- Department of Addiction Medicine, Hunan Institute of Mental Health, The Second People's Hospital of Hunan Province (Brain Hospital of Hunan Province), Changsha, Hunan, China.
- Fuzhou Neuropsychiatric Hospital Affiliated to Fujian Medical University, Fuzhou, Fujian, China.
- The Second General Hospital of Fuzhou Neuropsychiatric Prevention and Treatment Hospital, Fuzhou, Fujian, China.
- College of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha, Hunan, China.
ORCID-Profile: Jubo Yin, Xuhui Zhou
Förderung
- Hunan Provincial Health High-Level Talent Scientific Research Project
- Key Project of Natural Science Foundation of Hunan Province
- Hunan Provincial Clinical Research Center for Addiction Disorder
- National Cultivation Project of Key Clinical Specialty (Addiction medicine)
- Hunan Province clinical key specialty (Addiction medicine)
- Key Clinical Specialty Construction Project of the Hunan Health Commission (Improvement of Diagnosis and Treatment Ability of Severe Psychiatric Diseases in Hu…
Zitieren
APA
Huang, L., Zhou, B., Ou, Q., Yin, J., Tian, X., & Zhou, X. (2026). A Membrane‐Centric Plasma Lipidomic Signature of Response to Long‐Acting Naltrexone in Alcohol Use Disorder. Addiction Biology, 31(5). https://doi.org/10.1111/adb.70165
Vancouver
Huang L, Zhou B, Ou Q, Yin J, Tian X, Zhou X. A Membrane‐Centric Plasma Lipidomic Signature of Response to Long‐Acting Naltrexone in Alcohol Use Disorder. Addiction Biology. 2026;31(5). doi:10.1111/adb.70165
BibTeX
@article{Huang2026,
author = {Huang, Liyao and Zhou, Bojie and Ou, Qinling and Yin, Jubo and Tian, Xiwen and Zhou, Xuhui},
title = {A Membrane‐Centric Plasma Lipidomic Signature of Response to Long‐Acting Naltrexone in Alcohol Use Disorder},
journal = {Addiction Biology},
year = {2026},
volume = {31},
number = {5},
doi = {10.1111/adb.70165}
}
EUVIMED